New lupus shot tested for safety in 30 patients
NCT ID NCT06955598
First seen Jan 04, 2026 · Last updated May 09, 2026 · Updated 21 times
Summary
This early-stage study tested a new drug called SHR-2173 in 30 adults with systemic lupus erythematosus (SLE). The main goal was to see if multiple injections under the skin are safe and how the body processes the drug. Participants received the drug or placebo, and researchers monitored side effects and drug levels in the blood. This is not a cure; it is a first step toward finding a new treatment to help control lupus symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Renji Hospital affiliated to Shanghai Jiaotong
Shanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.